ClinicalTrials.Veeva

Menu

Development and Pilot Test of a Postnatal mHealth Intervention - Phase 2 (MESSAGE)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Knowledge, Attitudes, Practice
Acceptability of Health Care
Health Attitude
Post Partum Depression

Treatments

Behavioral: MESSSSAGE - live
Behavioral: MESSSSAGE - asynchronous

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04693585
R21HD101786 (U.S. NIH Grant/Contract)
R21HD101786-A

Details and patient eligibility

About

The goal of the study is to assess the feasibility and acceptability of the optimized MeSSSSage intervention which was developed and revised based on the results of our initial pilot testing. The investigators will conduct a controlled 4-arm factorial design randomized study to test the feasibility, acceptability and preliminary effectiveness of several intervention modalities over a 6-month period.

Full description

Most mHealth interventions for maternal and child health (MCH) in low and middle-income countries, including India, have focused on unidirectional and non-interactive approaches, primarily text messaging. However, ample evidence suggests that provider-led, interactive educational programming and social support are key for improving health behaviors and outcomes. Thus innovative mHealth approaches that promote interactive education and facilitate social support have great potential to improve MCH outcomes. The two-phase development of MeSSSSage include sPhase 1: exploratory development on functions and platforms and Phase 2: a mixed-methods randomized pilot study using a factorial design of specific intervention functions and platforms confirmed in Phase 1. Study activities described herein are associated with Phase 1. The study's specific aim is: To test the optimized intervention to understand the feasibility, acceptability and preliminary effectiveness of several intervention modalities among postnatal women in rural India. In Phase 2, the investigators conduct a randomized factorial design to understand the contribution to various intervention modalities on feasibility, accessibility and preliminary effectiveness. Data are collected via quantitative participant survey (baseline and endline) including sociodemographic characteristics and knowledge about maternal and infant health, self-efficacy, and perceived social norms regarding MCH-related health promoting behaviors (baseline) acceptability questions such as women's satisfaction with and perceptions of MeSSSSage, maternal and infant knowledge-, behavior-, and health-related questions including about breastfeeding, complementary food introduction, immunization, family planning uptake, maternal physical and mental health, etc. The investigators will validate self-report with health records. The investigators will conduct in-depth interviews among a purposive sample of 30 women to understand: mobile technology familiarity prior to intervention, perspectives on intervention and challenges, structure of intervention (group, individual), content, perspectives on the text-based component, relationship with other participants, perspective on the moderator, postnatal period health related concerns, sources of support (social and informational), recommendations. Other assessment will include technological data from, and group moderator surveys and interviews.

Enrollment

201 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Postnatal (within 2 weeks)
  • 18+ years old

Exclusion criteria

  • Women below 18 years of age
  • Women with high risk pregnancies
  • Women who delivered preterm, suffer severe maternal complications or they or their baby are otherwise sick in the first week

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

201 participants in 4 patient groups

Arm 1: live support
Experimental group
Description:
Real-time live voice call plus standard of postnatal care.
Treatment:
Behavioral: MESSSSAGE - live
Arm 2: asynchronous support
Experimental group
Description:
Text-based, asynchronous, on-demand social support plus standard of postnatal care
Treatment:
Behavioral: MESSSSAGE - asynchronous
Arm 3: both live and asynchronous support
Experimental group
Description:
Real-time live voice call plus standard of postnatal care; text-based, asynchronous, on-demand social support plus standard of postnatal care
Treatment:
Behavioral: MESSSSAGE - asynchronous
Behavioral: MESSSSAGE - live
Arm 4: control
No Intervention group
Description:
Standard of postnatal care.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Nadia G Diamond-Smith, PhD; Alison M El Ayadi, ScD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems